Diversion Control Division, US Department of Justice, Drug Enforcement Administration

COVID-19 Information Page

COVID-19 Information Page

Prescriptions | Registration | Quota |National Drug Supply | EPCS | Telemedicine | Medication Assisted Treatment | Records and Reports | Contacts | Important Federal Links | Important State Links

Picture of COVID-19 virus

The mission of Drug Enforcement Administrations (DEA), Diversion Control Division is to prevent, detect, and investigate the diversion of controlled pharmaceuticals and listed chemicals from legitimate sources while ensuring an adequate and uninterrupted supply for legitimate medical, commercial, and scientific needs.

During this National Emergency the Diversion Control Division will continue to work with our Federal partners, DEA registrants, and their representative association to assure that there is an adequate supply of controlled substances in the United States. The DEA will also work to assure that patients will have access to controlled substances.

Questions and Answers

Prescriptions

COVID-19 Prescribing Guidance
DEA Policy: COVID-19 Prescribing Guidance (For assistance contact Local DEA Field Office)

DEA Policy: Registrant Guidance on Controlled Substance Prescription Refills

DEA Policy: Exception to Separate Registration Requirements Across State Lines

DEA Policy: Exception to Regulations Emergency Oral CII Prescription


Registration

Registration of Emergency Temporary Sites: If you need to set up an emergency or temporary off-site location and use controlled substances, please contact DEA at Natural.Disaster@usdoj.gov. DEA will issue you a temporary registration number for each designated alternate location. This will enable the drug supply chain to continue uninterrupted and maintain patient access to needed controlled substances.

DEA Policy: Exception to Separate Registration Requirements Across State Lines

Quota

DEA Policy: 65% Bulk Manufacture Exception to Regulations

National Drug Supply

The DEA is unaware of any shortages of controlled substances at this time. DEA is working with the Food and Drug Administration (FDA) on monitoring the supply of controlled substances available to manufacture drug products during the COVID-19 Pandemic. Please see the link to the FDA’s website www.fda.gov for more information on FDA’s response.

If you are a patient who has been prescribed drug products made using controlled substances, you should know that DEA works closely with all registrants to ensure a consistent supply and assist with an appropriate emergency response at the federal level. Our mission is to ensure an adequate, uninterrupted supply of controlled substances, within a closed system of distribution.

DEA is in touch with controlled substance manufacturers, distributors, and importers, and is unaware of any controlled substance shortages at this time. If you are a DEA registered manufacturer, distributor, or importer of controlled substances and are having issues with your supply chain, please contact your local field office, or email DEA at: Natural.Disaster@usdoj.gov

Electronic Prescribing of Controlled Substance (EPCS)

DEA Policy: Questions and Answers for Prescribing Practitioners (EPCS)

DEA Guidance: Use of Mobile Devices in the Issuance of EPCS

Telemedicine

DEA Policy: Use of Telephone Evaluations to Initiate Buprenorphine Prescribing

On January 31, 2020, the Secretary of the Department of Health and Human Services issues a public health emergency (HHS Public Health Emergency Declaration).

Question: Can telemedicine now be used under the conditions outlined in Title 21, United States Code (U.S.C.), Section 802(54)(D)?

Answer: Yes. While a prescription for a controlled substance issued by means of the Internet (including telemedicine) must generally be predicated on an in-person medical evaluation (21 U.S.C. 829(e)), the Controlled Substances Act contains certain exceptions to this requirement. One such exception occurs when the Secretary of Health and Human Services has declared a public health emergency under 42 U.S.C. 247d (section 319 of the Public Health Service Act), as set forth in 21 U.S.C. 802(54)(D). Secretary Azar declared such a public health emergency with regard to COVID-19 on January 31, 2020 (https://www.hhs.gov/about/news/2020/01/31/secretary-azar-declares-public-health-emergency-us-2019-novel-coronavirus.html). On March 16, 2020, the Secretary, with the concurrence of the Acting DEA Administrator, designated that the telemedicine allowance under section 802(54)(D) applies to all schedule II-V controlled substances in all areas of the United States. Accordingly, as of March 16, 2020, and continuing for as long as the Secretary’s designation of a public health emergency remains in effect, DEA-registered practitioners in all areas of the United States may issue prescriptions for all schedule II-V controlled substances to patients for whom they have not conducted an in-person medical evaluation, provided all of the following conditions are met:

  • The prescription is issued for a legitimate medical purpose by a practitioner acting in the usual course of his/her professional practice;
  • The telemedicine communication is conducted using an audio-visual, real-time, two-way interactive communication system; and
  • The practitioner is acting in accordance with applicable Federal and State laws.

Provided the practitioner satisfies the above requirements, the practitioner may issue the prescription using any of the methods of prescribing currently available and in the manner set forth in the DEA regulations. Thus, the practitioner may issue a prescription either electronically (for schedules II-V) or by calling in an emergency schedule II prescription to the pharmacy, or by calling in a schedule III-V prescription to the pharmacy.

The term "practitioner" in this context includes a physician, dentist, veterinarian, or other person licensed, registered, or otherwise permitted, by the United States or the jurisdiction in which s/he practices to prescribe controlled substances in the course of his/her professional practice (21 U.S.C. 802(21)).

Important note: If the prescribing practitioner has previously conducted an in-person medical evaluation of the patient, the practitioner may issue a prescription for a controlled substance after having communicated with the patient via telemedicine, or any other means, regardless of whether a public health emergency has been declared by the Secretary of Health and Human Services, so long as the prescription is issued for a legitimate medical purpose and the practitioner is acting in the usual course of his/her professional practice. In addition, for the prescription to be valid, the practitioner must comply with applicable Federal and State laws.

Medication Assisted Treatment (MAT)

DEA Policy: Use of Telephone Evaluations to Initiate Buprenorphine Prescribing

DEA Guidance: Exemption Allowing Alternate Delivery Methods for OTPs

Substance Abuse and Mental Health Services Administration (SAMHSA): OTP Update Page

SAMHSA: COVID-19 Guidance for Opioid Treatment Programs

DEA Guidance: Methadone Shortages

Records and Reports

DEA Policy: Exception to Regulations to Email or Fax DEA Form 222’s

Important DEA Contacts:

Diversion Control Division (DEA HQ)

Find Your Local Diversion Field Office

Contact Local Registration Specialist

Liaison Section

Natural Disaster (COVID-19)

Policy Section

Important Federal Links

Government Response to Coronavirus, COVID-19

Centers for Disease Control and Prevention

Department of Health and Human Services

Substance Abuse and Mental Health Services Administration

DEA Significant Guidance Document Portal

Federal Emergency Management Agency

Coronavirus.gov

Important State Links

Jump to: Alabama-Florida | Georgia-Kentucky | Louisiana-North Dakota | Ohio-Texas | Utah-Wyoming

Alabama

Alabama Board of Medical Examiners & Medical Licensure Commission of Alabama

Alabama Board of Pharmacy

Alabama Emergency Management Agency

Alabama Public Health

Alaska

Alaska State Medical Board

Alaska State Pharmacy Board

Alaska Division of Homeland Security & Emergency Management

Alaska Department of Health and Social Services

Arizona

Arizona Medical Board

Arizona State Board of Pharmacy

Arizona Department of Homeland Security

Arizona Department of Emergency and Military Affairs

Arizona Department of Health Services

Arkansas

Arkansas State Medical Board

Arkansas State Board of Pharmacy

Arkansas Division of Emergency Management

Arkansas Department of Health

California

Medical Board of California

California State Board of Pharmacy

California Governor’s Office of Emergency Services

California Department of Public Health

Colorado

Colorado Medical Board

Colorado State Pharmacy Board

Colorado Division of Homeland Security & Emergency Management

Colorado Department of Public Health and Environment

Connecticut

Connecticut Medical Examining Board

The Connecticut Commission of Pharmacy

Connecticut Division of Emergency Management and Homeland Security

Connecticut State Department of Public Health

Delaware

Delaware Board of Medical Licensure and Discipline

Delaware Board of Pharmacy

Delaware Department of Safety and Homeland Security

Delaware Emergency Management Agency

Delaware Health and Social Services

District of Columbia

District of Columbia Medical Board/Board of Health

District of Columbia Pharmacy Board

District of Columbia Emergency Management Services

DC Health

Florida

Florida Board of Medicine

Florida Board of Pharmacy

Florida Division of Emergency Management

Florida Health

Georgia

Georgia Composite Medical Board

Georgia Board of Pharmacy

Georgia Emergency Management and Homeland Security Agency

Georgia Department of Public Health

Hawaii

Hawaii Medical Board

Hawaii Board of Pharmacy

Hawaii Emergency Management Agency

Hawaii State Department of Health

Idaho

Idaho Board of Medicine

Idaho State Board of Pharmacy

Idaho Office of Emergency Management

Idaho Department of Health and Welfare

Illinois

Illinois Department of Financial and Professional Regulation – State Medical Licensing Board

Illinois Department of Financial and Professional Regulation – State Board of Pharmacy

Illinois Emergency Management Agency

Illinois Department of Public Health

Indiana

Medical Licensing Board of Indiana

Indiana Board of Pharmacy

Indiana Emergency Management – Indiana Department of Homeland Security

Indiana State Department of Health

Iowa

Iowa Board of Medicine

Iowa Board of Pharmacy

Iowa Homeland Security & Emergency Management

Iowa Department of Public Health

Kansas

Kansas Board of Healing Arts

Kansas Board of Pharmacy

Kansas Department of Emergency Management

Kansas Department of Health and Environment

Kentucky

Kentucky Board of Medical Licensure

Kentucky Board of Pharmacy

Kentucky Office of Homeland Security

Kentucky Emergency Management

Kentucky Department for Public Health

Louisiana

Louisiana State Board of Medical Examiners

Louisiana Board of Pharmacy

State of Louisiana Governor’s Office of Homeland Security and Emergency Preparedness

Louisiana Department of Health

Maine

Maine State Medical Board/Board of Health

Maine State Pharmacy Board

Maine Emergency Management Services

Maine Department of Health and Human Services

Maryland

Maryland State Medical Board/Board of Health

Maryland State Pharmacy Board

Maryland Emergency Management Services

Maryland Department of Health

Massachusetts

Massachusetts State Medical Board/Board of Health

Massachusetts State Pharmacy Board

Massachusetts Emergency Management Services

Massachusetts Department of Public Health

Michigan

Michigan State Medical Board

Michigan State Pharmacy Board/Department of Health

Michigan Emergency Management Services

Michigan Department of Health & Human Services

Minnesota

Minnesota State Medical Board

Minnesota State Pharmacy Board

Minnesota Emergency Management Services

Minnesota Department of Health

Mississippi

Mississippi State Medical Board

Mississippi State Pharmacy Board

Mississippi Emergency Management Services

Mississippi State Department of Health

Missouri

Missouri State Medical Board/Board of Health

Missouri State Pharmacy Board

Missouri Emergency Management Services

Missouri Department of Health & Senior Services

Montana

Montana State Medical Board/Board of Health

Montana State Pharmacy Board

Montana Emergency Management Services

Montana Department of Public Health and Human Services

Nebraska

Nebraska State Medical Board/Board of Health

Nebraska State Pharmacy Board

Nebraska Emergency Management Services

Nebraska Department of Health and Human Services

Nevada

Nevada State Medical Board/Board of Health

Nevada State Pharmacy Board

Nevada Emergency Management Services

Nevada Department of Health and Human Services

New Hampshire

New Hampshire State Medical Board/Board of Health

New Hampshire State Pharmacy Board

New Hampshire Emergency Management Services

New Hampshire Department of Health and Human Services

New Jersey

New Jersey State Medical Board/Board of Health

New Jersey State Pharmacy Board

New Jersey Emergency Management Services

New Jersey Department of Health

New Mexico

New Mexico State Medical Board/Board of Health

New Mexico State Pharmacy Board

New Mexico Emergency Management Services

New Mexico Department of Health

New York

New York State Medical Board/Board of Health

New York State Pharmacy Board

New York Emergency Management Services

New York Department of Health and Human Services

North Carolina

North Carolina State Medical Board/Board of Health

North Carolina State Pharmacy Board

North Carolina Emergency Management Services

North Carolina Department of Health and Human Services

North Dakota

North Dakota State Medical Board/Board of Health

North Dakota State Pharmacy Board

North Dakota Emergency Management Services

North Dakota Department of Health

Ohio

Ohio State Medical Board/Board of Health

Ohio State Pharmacy Board

Ohio Emergency Management Services

Ohio Department of Health

Oklahoma

Oklahoma State Medical Board/Board of Health

Oklahoma State Pharmacy Board

Oklahoma Emergency Management Services

Oklahoma State Department of Health

Oregon

Oregon State Medical Board/Board of Health

Oregon State Pharmacy Board

Oregon Emergency Management Services

Oregon Health Authority

Pennsylvania

Pennsylvania State Medical Board/Board of Health

Pennsylvania State Pharmacy Board

Pennsylvania Emergency Management Services

Pennsylvania Department of Health

Rhode Island

Rhode Island State Medical Board/Board of Health

Rhode Island State Pharmacy Board

Rhode Island Emergency Management Services

State of Rhode Island Department of Health

South Carolina

South Carolina State Medical Board/Board of Health

South Carolina State Pharmacy Board

South Carolina Emergency Management Services

South Carolina Department of Health and Environmental Control

South Dakota

South Dakota State Medical Board/Board of Health

South Dakota State Pharmacy Board

South Dakota Emergency Management Services

South Dakota Department of Health

Tennessee

Tennessee State Medical Board/Board of Health

Tennessee State Pharmacy Board

Tennessee Emergency Management Services

Tennessee Department of Health

Texas

Texas State Medical Board/Board of Health

Texas State Pharmacy Board

Texas Emergency Management Services

Texas Department of State Health Services

Utah

Utah State Medical Board/Board of Health

Utah State Pharmacy Board

Utah Emergency Management Services

Utah Department of Health

Vermont

Vermont State Medical Board/Board of Health

Vermont State Pharmacy Board

Vermont Emergency Management Services

Vermont Department of Health

Virginia

Virginia State Medical Board/Board of Health

Virginia State Pharmacy Board

Virginia Emergency Management Services

Virginia Department of Health

Washington

Washington State Medical Board/Board of Health

Washington State Pharmacy Board

Washington Emergency Management Services

Washington State Department of Health

West Virginia

West Virginia State Medical Board/Board of Health

West Virginia State Pharmacy Board

West Virginia Emergency Management Services

West Virginia Department of Health & Human Resources, Bureau for Public Health, Office of Epidemiology & Prevention Services

Wisconsin

Wisconsin State Medical Board/Board of Health

Wisconsin State Pharmacy Board

Wisconsin Emergency Management Services

Wisconsin Department of Health Services

Wyoming

Wyoming State Medical Board/Board of Health

Wyoming State Pharmacy Board

Wyoming Emergency Management Services

Wyoming Department of Health

EO13891 Disclaimer: Guidance documents are not binding and lack the force and effect of law, unless expressly authorized by statute or expressly incorporated into a contract, grant, or cooperative agreement. Consistent with Executive Order 13891 and the Office of Management and Budget implementing memoranda, the Department will not cite, use, or rely on any guidance not so authorized or incorporated that is not accessible through this guidance portal, except to establish historical facts. To the extent any guidance document sets out voluntary standards (e.g., recommended practices), compliance with those standards is voluntary, and noncompliance will not result in enforcement action. Guidance documents may be rescinded or modified in the Department’s complete discretion, consistent with applicable laws.

Emergency Disaster Relief
National Prescription Drug Take Back Day. Turn in your unused or expired medication for safe disposal here.
RX Abuse Online

U.S. DEPARTMENT OF JUSTICE  •  DRUG ENFORCEMENT ADMINISTRATION
Diversion Control Division  •  8701 Morrissette Drive  •  Springfield, VA 22152  •  1-800-882-9539

DOJ Legal Policies and Disclaimers    |    DOJ Privacy Policy    |    FOIA    |    Section 508 Accessibility